BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38626765)

  • 1. Accumulation of APP C-terminal fragments causes endolysosomal dysfunction through the dysregulation of late endosome to lysosome-ER contact sites.
    Bretou M; Sannerud R; Escamilla-Ayala A; Leroy T; Vrancx C; Van Acker ZP; Perdok A; Vermeire W; Vorsters I; Van Keymolen S; Maxson M; Pavie B; Wierda K; Eskelinen EL; Annaert W
    Dev Cell; 2024 Jun; 59(12):1571-1592.e9. PubMed ID: 38626765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered γ-Secretase Processing of APP Disrupts Lysosome and Autophagosome Function in Monogenic Alzheimer's Disease.
    Hung COY; Livesey FJ
    Cell Rep; 2018 Dec; 25(13):3647-3660.e2. PubMed ID: 30590039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APP overexpression in the absence of NPC1 exacerbates metabolism of amyloidogenic proteins of Alzheimer's disease.
    Maulik M; Peake K; Chung J; Wang Y; Vance JE; Kar S
    Hum Mol Genet; 2015 Dec; 24(24):7132-50. PubMed ID: 26433932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer's disease models and human brains.
    Vaillant-Beuchot L; Mary A; Pardossi-Piquard R; Bourgeois A; Lauritzen I; Eysert F; Kinoshita PF; Cazareth J; Badot C; Fragaki K; Bussiere R; Martin C; Mary R; Bauer C; Pagnotta S; Paquis-Flucklinger V; Buée-Scherrer V; Buée L; Lacas-Gervais S; Checler F; Chami M
    Acta Neuropathol; 2021 Jan; 141(1):39-65. PubMed ID: 33079262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. η-Secretase processing of APP inhibits neuronal activity in the hippocampus.
    Willem M; Tahirovic S; Busche MA; Ovsepian SV; Chafai M; Kootar S; Hornburg D; Evans LD; Moore S; Daria A; Hampel H; Müller V; Giudici C; Nuscher B; Wenninger-Weinzierl A; Kremmer E; Heneka MT; Thal DR; Giedraitis V; Lannfelt L; Müller U; Livesey FJ; Meissner F; Herms J; Konnerth A; Marie H; Haass C
    Nature; 2015 Oct; 526(7573):443-7. PubMed ID: 26322584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of sphingosine-1-phosphate lyase impairs lysosomal metabolism of the amyloid precursor protein.
    Karaca I; Tamboli IY; Glebov K; Richter J; Fell LH; Grimm MO; Haupenthal VJ; Hartmann T; Gräler MH; van Echten-Deckert G; Walter J
    J Biol Chem; 2014 Jun; 289(24):16761-72. PubMed ID: 24808180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting γ-secretase triggers the selective enrichment of oligomeric APP-CTFs in brain extracellular vesicles from Alzheimer cell and mouse models.
    Lauritzen I; Bécot A; Bourgeois A; Pardossi-Piquard R; Biferi MG; Barkats M; Checler F
    Transl Neurodegener; 2019; 8():35. PubMed ID: 31827783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired axonal retrograde trafficking of the retromer complex augments lysosomal deficits in Alzheimer's disease neurons.
    Tammineni P; Jeong YY; Feng T; Aikal D; Cai Q
    Hum Mol Genet; 2017 Nov; 26(22):4352-4366. PubMed ID: 28973312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD2-associated protein (CD2AP) overexpression accelerates amyloid precursor protein (APP) transfer from early endosomes to the lysosomal degradation pathway.
    Furusawa K; Takasugi T; Chiu YW; Hori Y; Tomita T; Fukuda M; Hisanaga SI
    J Biol Chem; 2019 Jul; 294(28):10886-10899. PubMed ID: 31138646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presenilin/γ-Secretase Activity Is Located in Acidic Compartments of Live Neurons.
    Maesako M; Houser MCQ; Turchyna Y; Wolfe MS; Berezovska O
    J Neurosci; 2022 Jan; 42(1):145-154. PubMed ID: 34810230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclopamine modulates γ-secretase-mediated cleavage of amyloid precursor protein by altering its subcellular trafficking and lysosomal degradation.
    Vorobyeva AG; Lee R; Miller S; Longen C; Sharoni M; Kandelwal PJ; Kim FJ; Marenda DR; Saunders AJ
    J Biol Chem; 2014 Nov; 289(48):33258-74. PubMed ID: 25281744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing Aβ Generation and Amyloid Plaque Pathogenesis.
    Xiao Q; Yan P; Ma X; Liu H; Perez R; Zhu A; Gonzales E; Tripoli DL; Czerniewski L; Ballabio A; Cirrito JR; Diwan A; Lee JM
    J Neurosci; 2015 Sep; 35(35):12137-51. PubMed ID: 26338325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible Clues for Brain Energy Translation via Endolysosomal Trafficking of APP-CTFs in Alzheimer's Disease.
    Sivanesan S; Mundugaru R; Rajadas J
    Oxid Med Cell Longev; 2018; 2018():2764831. PubMed ID: 30420907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turnover of C99 is controlled by a crosstalk between ERAD and ubiquitin-independent lysosomal degradation in human neuroglioma cells.
    Bustamante HA; Rivera-Dictter A; Cavieres VA; Muñoz VC; González A; Lin Y; Mardones GA; Burgos PV
    PLoS One; 2013; 8(12):e83096. PubMed ID: 24376644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingolipid storage affects autophagic metabolism of the amyloid precursor protein and promotes Abeta generation.
    Tamboli IY; Hampel H; Tien NT; Tolksdorf K; Breiden B; Mathews PM; Saftig P; Sandhoff K; Walter J
    J Neurosci; 2011 Feb; 31(5):1837-49. PubMed ID: 21289194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99).
    Jiang Y; Sato Y; Im E; Berg M; Bordi M; Darji S; Kumar A; Mohan PS; Bandyopadhyay U; Diaz A; Cuervo AM; Nixon RA
    J Neurosci; 2019 Jul; 39(27):5255-5268. PubMed ID: 31043483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rab21, a Novel PS1 Interactor, Regulates γ-Secretase Activity via PS1 Subcellular Distribution.
    Sun Z; Xie Y; Chen Y; Yang Q; Quan Z; Dai R; Qing H
    Mol Neurobiol; 2018 May; 55(5):3841-3855. PubMed ID: 28547526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-microdomain localization of amyloid β-precursor protein (APP) C-terminal fragments is regulated by phosphorylation of the cytoplasmic Thr668 residue.
    Matsushima T; Saito Y; Elliott JI; Iijima-Ando K; Nishimura M; Kimura N; Hata S; Yamamoto T; Nakaya T; Suzuki T
    J Biol Chem; 2012 Jun; 287(23):19715-24. PubMed ID: 22511769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of truncated C-terminal fragments of the Alzheimer's disease amyloid protein precursor derived from sequential proteolytic pathways.
    Mosser S; Gerber H; Fraering PC
    J Neurochem; 2021 Mar; 156(6):943-956. PubMed ID: 32757390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxy-terminal fragment of amyloid precursor protein mediates lipid droplet accumulation upon γ-secretase inhibition.
    Oikawa N; Fabiano M; Müller UC; Walter J
    Biochem Biophys Res Commun; 2021 Sep; 570():137-142. PubMed ID: 34280617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.